The company is seeking approval to use the assay to screen for HBV on both its semi-automated instrument platform and on the fully automated, high-throughput Tigris system. Hank
Spacelabs patient monitors provide clinicians with a large display unit and comprehensive monitoring capabilities at the bedside while also enabling clinicians to monitor patients wirelessly as they are
The decision prevents Ranbaxy from launching its drug before Lipitor’s basic patent expires in November 2011. Ranbaxy can seek to appeal the decision to the Supreme Court of
An initial Phase I pharmacokinetics, biodistribution and dosimetry study (BC1-08) with Alpharadin in HRPC patients with skeletal metastases will be conducted at the Memorial Sloan-Kettering Cancer Center in
The trial was initiated after the approval from the Medicines and Healthcare Products Regulatory Agency [MHRA] in the UK. The company intends to develop GRC 4039, a PDE
Under an exclusive marketing agreement, Neurobiological receives quarterly royalty payments on sales of Memantine by Merz and its marketing partners. Paul Freiman, president and CEO of Neurobiological, said:
Under the terms of the agreement VersaWave and DioDent Micro 980 lasers will be utilized at LVI’s state-of-the-art teaching facility through 2009. The educational alliance is the latest
Under the terms of the agreement, Celgene and Acceleron will jointly develop, manufacture and commercialize Acceleron’s products for bone loss. Celgene will make an upfront payment to Acceleron
Upon approval from the FDA, Addrenex and its licensing partner Sciele Pharma, will launch the drug in the first half of 2009. Patrick Fourteau, CEO of Sciele, said:
pSivida gets this payment under the terms of the exclusive worldwide collaborative research and license agreement for pSivida’s controlled drug delivery technologies in ophthalmic applications. Over the last
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.